Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.

about

MGCD0103 induces apoptosis and simultaneously increases the expression of NF-κB and PD-L1 in classical Hodgkin's lymphoma

P2860

Q57787094-33088721-E7F8-4C49-952A-844AD63B223E

P2860

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q54967313

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Clinicopathological features a ...... in classical Hodgkin lymphoma.

@en

Clinicopathological features a ...... in classical Hodgkin lymphoma.

@nl

type

Item

label

Clinicopathological features a ...... in classical Hodgkin lymphoma.

@en

Clinicopathological features a ...... in classical Hodgkin lymphoma.

@nl

prefLabel

Clinicopathological features a ...... in classical Hodgkin lymphoma.

@en

Clinicopathological features a ...... in classical Hodgkin lymphoma.

@nl

P1476

Clinicopathological features a ...... in classical Hodgkin lymphoma.

@en

P2093

Renhong Huang

http://www.w3.org/2001/XMLSchema#string

Sadia Sophia

http://www.w3.org/2001/XMLSchema#string

Xiaojian Liu

http://www.w3.org/2001/XMLSchema#string

Xiaowei Zhang

http://www.w3.org/2001/XMLSchema#string

Zhijun Min

http://www.w3.org/2001/XMLSchema#string

P2860

PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells

Light-controlled modulation of gene expression by chemical optoepigenetic probes

Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.

Histone deacetylase inhibitors in Hodgkin lymphoma.

HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma.

HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation.

Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors.

Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy.

Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.

Regulation of histone modifying enzymes by the ubiquitin-proteasome system.

P304

364-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CAD.0000000000000610

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29481474

http://www.w3.org/2001/XMLSchema#string

P932

5882292

http://www.w3.org/2001/XMLSchema#string

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.

about

P2860

P2860

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932